In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

Finally, a few studies in mice have found that the medications can reduce the buildup of the protein tau in the brain, which is a key contributor to Alzheimer’s disease. Scaling back tau buildup could ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Purdue researchers were awarded the Presidential Early Career Award for Scientists and Engineers by the U.S. government ...

The key is the ligand — that’s the general word for whatever chemical messenger or ... For GLP-1 receptors, it’s GLP-1. Ozempic, or semaglutide, is a GLP-1 agonist, meaning its molecules mimic the ...

The key is the ligand — that’s the general word for whatever chemical ... it’s GLP-1. Ozempic, or semaglutide, is a GLP-1 agonist, meaning its molecules mimic the structure of GLP-1, binding ...

Ozempic alternatives offer a variety of options for those who want to switch due to side effects, availability, or cost. Below is a breakdown of readily available alternatives, all vetted by our ...

Ziyad Al-Aly receives funding from U.S. Department of Veterans Affairs. Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising ...

“Ozempic neck” refers to the appearance of ... (Endocrinologists are knowledgeable in the function and structure of the endocrine glands, as well as endocrine disorders. The endocrine glands ...